REFERENCES
- Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., Witzenbichler B., Schatteman G., Isner J. M. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964–967
- Assmus B., Schachinger V., Teupe C., Britten M., Lehmann R., Dobert N., Grunwald F., Aicher A., Urbich C., Martin H., Hoelzer D., Dimmeler S., Zeiher A M. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002; 106: 3009–3017
- Assmus B., Urbich C., Aicher A., Hofmann W K., Haendeler J., Rossig L., Spyridopoulos I., Zeiher A M., Dimmeler S. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Circulation Research 2003; 92: 1049–1055
- Delva P., Degan M., Vallerio P., Arosio E., Minuz P., Amen G., Di Chio M., Lechi A. Endothelial progenitor cells in patients with essential hypertension. Journal of Hypertension 2007; 25: 127–132
- Fadini G P., Sartore S., Albiero M., Baesso I., Murphy E., Menegolo M., Grego F., Vigili de Kreutzenberg S., Tiengo A., Agostini C., Avogaro A. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arteriosclerosis Thrombosis and Vascular Biology 2006; 26: 2140–2146
- Forsythe J A, Jiang B H, Iver N V, Agani F, Leung S V, Koos R D, Semenza G L. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Molecular and Cellular Biology 1996; 16: 4604–13
- Gehling U M., Ergun S., Schumacher U., Wagener C., Pantel K., Otte M., Schuch G., Schafhausen P., Mende T., Kilic N., Kluge K., Schafer B., Hossfeld D K., Fiedler W. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 2000; 95: 3106–311
- Gunsilius E., Duba H C., Petzer A L., Kahler C M., Gastl G A. Contribution of endothelial cells of hematopoietic origin to blood vessel formation. Circulation Research 2001; 88: E1
- Güven H., Shepherd R M., Bach R G., Capoccia B J., Link D C. The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease. Journal of American College of Cardiology 2006; 48: 1579–1587
- Hill J M., Zalos G., Halcox J P., Schenke W H., Waclawiw M A., Ouvvumi A A., Finkel T. Circulating endothelial progenitor cells, vascular function and cardiovascular risk. New England Journal of Medicine 2003; 348: 593–600
- Imanishi T., Moriwaki Hano T., Nishio I. Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension. Journal of Hypertension 2005; 23: 1831–1837
- Ingram D A., Mead L E., Tanaka H., Meade V., Fenoglio A., Mortell K., Pollok K., Ferkowicz M J., Gilley D., Yoder M C. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbelical cord blood. Blood 2004; 104: 2752–2760
- Kalka C., Masuda H., Takahashi T., Kalka-Moll W M., Silver M., Kearney M., Li T., Isner J M., Asahara T. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proceedings of the National Academy of Science of the United States of America 2000; 97: 3422–3427
- Koshikawa M., Shimodaira S., Yoshioka T., Kasai H., Watanabe N., Wada Y., Seto T., Fukui D., Amano J., Ikeda U. Therapeutic angiogenesis by bone marrow implantation for critical hand ischemia in patients with peripheral arterial disease: A pilot study. Current Medical Research and Opinion 2006; 22: 793–798
- Peichev M., Naiyer A J., Pereira D., Zhu Z., Lane W J., Williams M., Oz M C., Hicklin D J., Witte L., Moore M A., Rafii S. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000; 95: 952–958
- Sandri M., Adams V., Gielen S., Linke A., Lenk K., Krankel N., Lenz D., Erbs S., Scheinert D., Mohr F W., Schuler G., Hambrecht R. Effects of exercise and ischemia on mobilization and functional activation of blood-derived progenitor cells in patients with ischemic syndromes. Results of 3 randomized studies. Circulation 2005; 111: 3391–3399
- Sata M. Molecular strategies to treat vascular diseases: Circulating vascular progenitors cell as a potential target for prophylactic treatment of atherosclerosis. Circulation Journal 2003; 67: 983–991
- Shintani S, Murohara T, Ikeda H, Ueno T, Honma T, Katoh A, Sasaki K, Shimada T, Oike Y, Imaizumi T. Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation 2001; 103: 897–903
- Shintani S., Murohara T., Ikeda H., Takafumi U., Tomoki H., Atsushi K., Ken-ichiro S., Toshifumi S., Yuichi O., Tsutomu I. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001; 103: 2776–2779
- Tateishi-Yuyama E., Matsubara H., Murohara T., Ikeda U., Shintani S., Masaki H., Amano K., Kishimoto Y., Yoshimoto K., Akashi H., Shimada K., Iwasaka T., Imaizumi T. Therapeutic angiogenesis for patients with limb ischemia by autologous transplantation of bone marrow cells: A pilot study and a randomized controlled trial. Lancet 2002; 360: 427–435
- Tepper O M., Galiano R D., Capla J M., Kalka C., Gagne P J., Jacobowitz G R., Levine J P., Gurtner G C. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion and incorporation into vascular structures. Circulation 2002; 106: 2781–2786
- Tse H F., Kwong Y L., Chan J KF., Lo G., Ho C L., Lau C P. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 2003; 361: 47–49
- Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., Zeiher A M., Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circualtion Research 2001; 89: e1–e7
- Werner N, Kosiol S, Schiegl T, Ahlers P, Talenta K, Link A, Bohm M, Nickenig G. Circulating endothelial progenitor cells and cardiovascular outcomes. New England Journal of Medicine 2005; 353: 999–1007